Home

Schizophenia Drugs

1999-12-09T00:00:00

Exciting claims about what 'atypical' antipsychotic drugs can do are marred by the poor quality of much of the research evidence, say Paul Wilson, Simon Gilbody and Anne-Marie Bagnall

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here